Clinical Trial Update: Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating donor peripheral blood stem cell transplantation in combination with pretargeted radioimmunotherapy for patients with high-risk advance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Anemia with Excess Blasts
• Cytopenia with Multilineage Dysplasia
• Myelodysplastic Myeloproliferative Neoplasm Unclassifiable
• Myelodysplastic Syndrome
• Myelomonocytic Leukemia

Drugs mentioned

• Donor peripheral blood stem cell transplant
• Pretargeted radioimmunotherapy

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Chronic Myelomonocytic Leukemia, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable | Phase 1 | Status: COMPLETED